Polaryx Therapeutics Inc (PLYX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.00+0.50%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PLYX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Operating Expenses & Income | |||
| R&D Expenses | 6.3 | 2.8 | — |
| Operating Income | (7.8) | (4.4) | — |
| Earnings from Continuing Operations | |||
| EBT, Incl. Unusual Items | (9.0) | (30.4) | — |
| Net Income | |||
| Net Income | (9.0) | (30.4) | — |
| Per Share | |||
| Basic EPS | (0.20) | (0.89) | — |
| Diluted EPS | (0.20) | (0.89) | — |
| Basic Weighted Avg Shares | 45.4 | 34.2 | — |
| Diluted Weighted Avg Shares | 45.4 | 34.2 | — |
| Supplemental | |||
| EBIT | (7.8) | (4.4) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.